Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid TumorsContributed by: Business WireLogoTagsOncologyHealthBiometricsHealth TechnologyGeneticsPharmaceuticalBiotechnologyQIAGEN